Who Buys Cyclosporine from India — 319 Importers Behind a $12.1M Market
India's cyclosporine import market is served by 319 active buyers who collectively imported $12.1M across 2,531 shipments. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED (TURKEY) leads with a 19.6% market share, followed by AVET PHARMACCEUTICALS INC., and AVET PHARMACCEUTICALS INC. The top 5 buyers together control 49.1% of total import value, reflecting a moderately competitive buyer landscape.
Top Cyclosporine Importers — Ranked by Import Value
PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED (TURKEY) is the leading cyclosporine importer from India, holding a 19.6% share of the $12.1M market across 2,531 shipments from 319 buyers. The top 5 buyers — PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED (TURKEY), AVET PHARMACCEUTICALS INC., (UNITED STATES), AVET PHARMACCEUTICALS INC (UNITED STATES), AVET PHARMACCEUTICALS INC. (UNITED STATES), M/S ARABIAN OASIS COMPANY (SAUDI ARABIA) — collectively control 49.1% of total import value.
Top Cyclosporine Buyers & Importers
Ranked by import value · 319 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITEDTURKEY CYCLOSPORINE 100MG CONIMUNE ME 100MG CAP-CYCLOSPORINE 50MG CONIMUNE ME 50MG CAP6X5SCYCLOSPORINE 50MG CONIMUNE ME 50MG CAP- | $2.4M | 5 | 19.6% |
| 2 | AVET PHARMACCEUTICALS INC.,UNITED STATES | $1.8M | 5 | 14.7% |
| 3 | AVET PHARMACCEUTICALS INCUNITED STATES | $1.1M | 5 | 9.2% |
| 4 | AVET PHARMACCEUTICALS INC.UNITED STATES | $348.5K | 5 | 2.9% |
| 5 | M/S ARABIAN OASIS COMPANYSAUDI ARABIA CYCLOSPORINE CAPSULES I.P. SANDIMMUN NEO | $335.6K | 5 | 2.8% |
| 6 | REPUBLIC OF YEMEN CLIENT CODEYEMEN NEORAL 50MG - CYCLOSPORINE CAPSULES 50MG BOX OF 50 CAPSNEORAL 50MG - CYCLOSPORINE CAPSULES 50MGNEORAL 25MG - CYCLOSPORINE CAPSULES 25MG | $280.9K | 5 | 2.3% |
| 7 | REGENCY PHARMA LIMITEDMAURITIUS CYCLOMUNE EYE DROP 0.05% W/V 3 ML CYCLOSPORINE | $276.0K | 5 | 2.3% |
| 8 | REPUBLIC OF YEMEN CLIENT CODE 02YEMEN NEORAL 50MG - CYCLOSPORINE CAPSULES 50MG BOX OF 50 CAPSNEORAL 50MG - CYCLOSPORINE CAPSULES 50MGNEORAL 25MG - CYCLOSPORINE CAPSULES 25MG | $203.5K | 5 | 1.7% |
| 9 | ARABIAN OASIS COMPANYSAUDI ARABIA CYCLOSPORINE CAPSULES I.P. SANDIMMUN NEO | $157.3K | 5 | 1.3% |
| 10 | FHC-FARMACEUTICA S APORTUGAL | $138.4K | 5 | 1.1% |
| 11 | STATE PHARMACEUTICALS CORPORATIONSRI LANKA | $125.9K | 5 | 1.0% |
| 12 | INTERNATIONAL TRADING OFFICEEGYPT CYCLOSPORINE 100MG CONIMUNE ME 100MG CAP-CYCLOSPORINE 50MG CONIMUNE ME 50MG CAP6X5SCYCLOSPORINE 50MG CONIMUNE ME 50MG CAP- | $111.6K | 5 | 0.9% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Cyclosporine — and from which countries?
Flow of Cyclosporine exports from India: each country's share and the named importers behind the numbers
Cyclosporine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $3.2M through 60 shipments. This represents a market share of 26.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• AVET PHARMACCEUTICALS INC., - $1.8M (54.9% of country's total business)
• AVET PHARMACCEUTICALS INC - $1.1M (34.3% of country's total business)
• AVET PHARMACCEUTICALS INC. - $348.5K (10.7% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $54.1K, indicating premium pricing strategy compared to the market average of $4.8K.
United States is a key market for Cyclosporine imports, representing 26.8% of total trade value.
2Turkey
Turkey emerges as the second largest importing country, achieving a total trade value of $2.7M through 14 shipments. This represents a market share of 22.6% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Turkey has a diverse importer base, with their top importers including:
• PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED - $2.4M (86.6% of country's total business)
Key Insight: Turkey demonstrates strong market positioning with an average shipment value of $196.0K, indicating premium pricing strategy compared to the market average of $4.8K.
Turkey is a key market for Cyclosporine imports, representing 22.6% of total trade value.
3Ecuador
Ecuador emerges as the third largest importing country, achieving a total trade value of $1.3M through 0 shipments. This represents a market share of 10.4% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Ecuador demonstrates strong market positioning with an average shipment value of $1.3M, indicating premium pricing strategy compared to the market average of $4.8K.
Ecuador is a key market for Cyclosporine imports, representing 10.4% of total trade value.
4United Arab Emirates
United Arab Emirates emerges as the fourth largest importing country, achieving a total trade value of $992.0K through 0 shipments. This represents a market share of 8.2% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: United Arab Emirates demonstrates strong market positioning with an average shipment value of $992.0K, indicating premium pricing strategy compared to the market average of $4.8K.
United Arab Emirates is a key market for Cyclosporine imports, representing 8.2% of total trade value.
5Saudi Arabia
Saudi Arabia emerges as the fifth largest importing country, achieving a total trade value of $581.3K through 18 shipments. This represents a market share of 4.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Saudi Arabia has a diverse importer base, with their top importers including:
• M/S ARABIAN OASIS COMPANY - $335.6K (57.7% of country's total business)
• ARABIAN OASIS COMPANY - $157.3K (27.1% of country's total business)
Key Insight: Saudi Arabia demonstrates strong market positioning with an average shipment value of $32.3K, indicating premium pricing strategy compared to the market average of $4.8K.
Saudi Arabia is a key market for Cyclosporine imports, representing 4.8% of total trade value.
Buyer Segment Analysis
TransData Nexus Cyclosporine buyer market intelligence
1Buyer Segment Analysis
The 319 buyers of Cyclosporine from India can be categorized into several segments:
1. Distributors: Entities that purchase Cyclosporine in bulk to supply to various healthcare providers.
2. Contract Manufacturers: Companies that procure Cyclosporine as an active pharmaceutical ingredient (API) for the production of finished dosage forms.
3. Government Procurement Agencies: National or regional health authorities that purchase medicines for public healthcare systems.
4. Re-exporters: Companies that import Cyclosporine for the purpose of exporting to other markets.
Typical buying behaviors vary by segment. Distributors and contract manufacturers often place large, regular orders to maintain supply chains and meet production schedules. Government procurement agencies may engage in tender-based purchasing, leading to bulk orders at specific intervals. Re-exporters' purchasing patterns depend on demand fluctuations in their target markets.
Country-Specific Import Regulations
TransData Nexus Cyclosporine buyer market intelligence
1Country-Specific Import Regulations
United States
- 1Regulatory Authority: U.S. Food and Drug Administration (FDA).
- 2Import Registration Process: Importers must ensure that Cyclosporine products comply with FDA regulations, including proper labeling and adherence to the Federal Food, Drug, and Cosmetic Act.
- 3Estimated Timeline for Registration: The FDA does not require a specific import registration for Cyclosporine; however, compliance with FDA regulations is mandatory.
- 4Import Tariff/Duty: Cyclosporine Ophthalmic Emulsion 0.05% falls under HTSUS subheading 3004.90.9285, which is duty-free.
Turkey
- 1Regulatory Authority: Turkish Medicines and Medical Devices Agency (TİTCK).
- 2Import Registration Process: Importers must obtain a license from TİTCK, ensuring that the product meets Turkish pharmaceutical standards.
- 3Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and compliance with regulations.
- 4Import Tariff/Duty: Specific tariff information for HS code 30049099 should be verified with Turkish customs authorities, as rates may vary.
Ecuador
- 1Regulatory Authority: National Agency for Health Regulation, Control, and Surveillance (ARCSA).
- 2Import Registration Process: Importers must register pharmaceutical products with ARCSA, providing necessary documentation and samples.
- 3Estimated Timeline for Registration: The process typically takes 6 to 12 months, subject to regulatory review.
- 4Import Tariff/Duty: Import duties for pharmaceuticals under HS code 30049099 should be confirmed with Ecuadorian customs, as they are subject to change.
United Arab Emirates
- 1Regulatory Authority: Ministry of Health and Prevention (MOHAP).
- 2Import Registration Process: Importers must register pharmaceutical products with MOHAP, ensuring compliance with UAE regulations.
- 3Estimated Timeline for Registration: The registration process can take approximately 6 months, depending on the submission's accuracy and completeness.
- 4Import Tariff/Duty: The UAE imposes a 5% import duty on most pharmaceutical products; however, exemptions may apply.
Saudi Arabia
- 1Regulatory Authority: Saudi Food and Drug Authority (SFDA).
- 2Import Registration Process: Importers must register pharmaceutical products with the SFDA, providing a Certificate of Free Sale and other required documentation.
- 3Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and compliance with regulations.
- 4Import Tariff/Duty: Import duties for pharmaceuticals under HS code 30049099 should be confirmed with Saudi customs authorities, as rates may vary.
Demand Drivers & Market Opportunity
TransData Nexus Cyclosporine buyer market intelligence
1Demand Drivers & Market Opportunity
Demand for Cyclosporine in importing countries is driven by several factors:
1. Disease Prevalence: Cyclosporine is primarily used for organ transplant patients to prevent rejection and in treating certain autoimmune diseases. The prevalence of these conditions necessitates a steady demand for immunosuppressive therapies.
2. Government Healthcare Programs: Many countries have national health programs that subsidize or provide essential medicines, including immunosuppressants, to their populations. For instance, Turkey's healthcare system aims to ensure the availability of essential medicines for chronic diseases. (emro.who.int)
3. Universal Health Coverage Expansion: Efforts to achieve Universal Health Coverage (UHC) increase access to essential medicines. The WHO emphasizes the importance of essential medicines in attaining UHC, which includes treatments like Cyclosporine.
4. WHO Essential Medicines List Procurement: Cyclosporine is listed on the WHO Model List of Essential Medicines, guiding countries in prioritizing its procurement to meet public health needs.
5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through competitive tendering processes, ensuring cost-effective and reliable supply chains for essential drugs like Cyclosporine.
With 319 buyers across 100 countries, the global demand for Cyclosporine reflects its critical role in healthcare systems worldwide. The combination of disease prevalence, supportive government policies, and international guidelines underscores the sustained market opportunity for this immunosuppressant.
Common Questions — Cyclosporine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest cyclosporine buyer importing from India?
Based on import volume and value, PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED (TURKEY) leads with $2.4M in imports and a 19.6% market share — the highest of any single cyclosporine importer. AVET PHARMACCEUTICALS INC., (UNITED STATES) and AVET PHARMACCEUTICALS INC (UNITED STATES) are the next largest buyers.
QHow many companies buy cyclosporine from India?
There are 319 active cyclosporine buyers importing from India, with a combined market of $12.1M across 2,531 shipments to 100 countries. The top 5 buyers hold 49.1% of total import value, while the remaining 314 buyers handle the other 50.9%.
QWhich countries import the most cyclosporine from India?
The top importing countries for cyclosporine from India are United States (26.8%), Turkey (22.6%), Ecuador (10.4%), United Arab Emirates (8.2%), Saudi Arabia (4.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of cyclosporine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for cyclosporine from India?
The average import transaction value for cyclosporine from India is $4.8K, with an average unit price of $14.74 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Cyclosporine buyer market intelligence
1Buyer Segment Analysis
The 319 buyers of Cyclosporine from India can be categorized into several segments:
1. Distributors: Entities that purchase Cyclosporine in bulk to supply to various healthcare providers.
2. Contract Manufacturers: Companies that procure Cyclosporine as an active pharmaceutical ingredient (API) for the production of finished dosage forms.
3. Government Procurement Agencies: National or regional health authorities that purchase medicines for public healthcare systems.
4. Re-exporters: Companies that import Cyclosporine for the purpose of exporting to other markets.
Typical buying behaviors vary by segment. Distributors and contract manufacturers often place large, regular orders to maintain supply chains and meet production schedules. Government procurement agencies may engage in tender-based purchasing, leading to bulk orders at specific intervals. Re-exporters' purchasing patterns depend on demand fluctuations in their target markets.
Country-Specific Import Regulations
TransData Nexus Cyclosporine buyer market intelligence
1Country-Specific Import Regulations
United States
- 1Regulatory Authority: U.S. Food and Drug Administration (FDA).
- 2Import Registration Process: Importers must ensure that Cyclosporine products comply with FDA regulations, including proper labeling and adherence to the Federal Food, Drug, and Cosmetic Act.
- 3Estimated Timeline for Registration: The FDA does not require a specific import registration for Cyclosporine; however, compliance with FDA regulations is mandatory.
- 4Import Tariff/Duty: Cyclosporine Ophthalmic Emulsion 0.05% falls under HTSUS subheading 3004.90.9285, which is duty-free.
Turkey
- 1Regulatory Authority: Turkish Medicines and Medical Devices Agency (TİTCK).
- 2Import Registration Process: Importers must obtain a license from TİTCK, ensuring that the product meets Turkish pharmaceutical standards.
- 3Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and compliance with regulations.
- 4Import Tariff/Duty: Specific tariff information for HS code 30049099 should be verified with Turkish customs authorities, as rates may vary.
Ecuador
- 1Regulatory Authority: National Agency for Health Regulation, Control, and Surveillance (ARCSA).
- 2Import Registration Process: Importers must register pharmaceutical products with ARCSA, providing necessary documentation and samples.
- 3Estimated Timeline for Registration: The process typically takes 6 to 12 months, subject to regulatory review.
- 4Import Tariff/Duty: Import duties for pharmaceuticals under HS code 30049099 should be confirmed with Ecuadorian customs, as they are subject to change.
United Arab Emirates
- 1Regulatory Authority: Ministry of Health and Prevention (MOHAP).
- 2Import Registration Process: Importers must register pharmaceutical products with MOHAP, ensuring compliance with UAE regulations.
- 3Estimated Timeline for Registration: The registration process can take approximately 6 months, depending on the submission's accuracy and completeness.
- 4Import Tariff/Duty: The UAE imposes a 5% import duty on most pharmaceutical products; however, exemptions may apply.
Saudi Arabia
- 1Regulatory Authority: Saudi Food and Drug Authority (SFDA).
- 2Import Registration Process: Importers must register pharmaceutical products with the SFDA, providing a Certificate of Free Sale and other required documentation.
- 3Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and compliance with regulations.
- 4Import Tariff/Duty: Import duties for pharmaceuticals under HS code 30049099 should be confirmed with Saudi customs authorities, as rates may vary.
Demand Drivers & Market Opportunity
TransData Nexus Cyclosporine buyer market intelligence
1Demand Drivers & Market Opportunity
Demand for Cyclosporine in importing countries is driven by several factors:
1. Disease Prevalence: Cyclosporine is primarily used for organ transplant patients to prevent rejection and in treating certain autoimmune diseases. The prevalence of these conditions necessitates a steady demand for immunosuppressive therapies.
2. Government Healthcare Programs: Many countries have national health programs that subsidize or provide essential medicines, including immunosuppressants, to their populations. For instance, Turkey's healthcare system aims to ensure the availability of essential medicines for chronic diseases. (emro.who.int)
3. Universal Health Coverage Expansion: Efforts to achieve Universal Health Coverage (UHC) increase access to essential medicines. The WHO emphasizes the importance of essential medicines in attaining UHC, which includes treatments like Cyclosporine.
4. WHO Essential Medicines List Procurement: Cyclosporine is listed on the WHO Model List of Essential Medicines, guiding countries in prioritizing its procurement to meet public health needs.
5. Tender-Based Purchasing: Many governments and large healthcare providers procure medicines through competitive tendering processes, ensuring cost-effective and reliable supply chains for essential drugs like Cyclosporine.
With 319 buyers across 100 countries, the global demand for Cyclosporine reflects its critical role in healthcare systems worldwide. The combination of disease prevalence, supportive government policies, and international guidelines underscores the sustained market opportunity for this immunosuppressant.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 319 global importers of Cyclosporine identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 2,531 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 100 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,531 Verified Shipments
319 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists